Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950129-08-001756
Filing Date
2008-03-17
Accepted
2008-03-17 17:15:10
Documents
8
Period of Report
2007-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K - ANNUAL REPORT h55008e10vk.htm 10-K 781006
2 SUBSIDIARIES OF THE REGISTRANT h55008exv21w1.htm EX-21.1 9407
3 CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM h55008exv23w1.htm EX-23.1 2877
4 CERTIFICATION OF CEO PURSUANT TO RULE 13A-14(A) h55008exv31w1.htm EX-31.1 7724
5 CERTIFICATION OF CFO PURSUANT TO RULE 13A-14(A) h55008exv31w2.htm EX-31.2 7798
6 CERTIFICATION PURSUANT TO SECTION 906 h55008exv32w1.htm EX-32.1 3036
7 CERTIFICATION PURSUANT TO SECTION 906 h55008exv32w2.htm EX-32.2 3129
8 GRAPHIC h55008h5500801.gif GRAPHIC 11807
  Complete submission text file 0000950129-08-001756.txt   832941
Mailing Address 4848 LOOP CENTRAL DRIVE SUITE 700 HOUSTON TX 77081
Business Address 4848 LOOP CENTRAL DRIVE SUITE 700 HOUSTON TX 77081 7137968822
ENCYSIVE PHARMACEUTICALS INC (Filer) CIK: 0000887023 (see all company filings)

EIN.: 133532643 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-20117 | Film No.: 08693944
SIC: 2834 Pharmaceutical Preparations